3D QSAR studies on GSK-3 inhibition by aloisines

被引:17
|
作者
Zeng, M [1 ]
Jiang, YJ [1 ]
Zhang, B [1 ]
Zheng, KW [1 ]
Zhang, N [1 ]
Yu, QS [1 ]
机构
[1] Zhejiang Univ, Key Lab Mol Design & Nutr Engn, Ningbo Inst Technol, Ningbo 315100, Zhejiang Prov, Peoples R China
关键词
3D-QSAR; GSK-3; aloisines;
D O I
10.1016/j.bmcl.2004.10.060
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
GSK-3 is involved in various physiological processes and its inhibitors have been evaluated as promising drug candidates for a lot of unmet pathologies. In this paper, inhibition of GSK-3 by aloisines is investigated by 3D QSAR studies. Two alignment rules were applied to check the influence of spatial alignment of the compounds. Both the CoMFA and CoMSIA techniques were carried out and ASS procedure was applied for CoMFA to find a satisfactory model. The best QSAR model obtained is a CoMSIA model characterized with r(2) of 0.938 and q(2) of 0.673 including steric, electrostatic and hydrophobic fields, possessing good predicting ability. To get a better understanding of the relationship between chemical structure and biological activity, a complex structure of aloisine with GSK-3 was obtained by superimposing GSK-3 into the known cocrystal structure of aloisine-CDK2, and then factors that affect the inhibition activity were investigated further, combining the QSAR study with the complex structure, the results of which are in good accordance and complementary to each other. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:395 / 399
页数:5
相关论文
共 50 条
  • [31] Use of molecular modeling, docking, and 3D-QSAR studies for the determination of the binding mode of benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3β inhibitors
    Ki Hwan Kim
    Irina Gaisina
    Franck Gallier
    Denise Holzle
    Sylvie Y. Blond
    Andrew Mesecar
    Alan P. Kozikowski
    Journal of Molecular Modeling, 2009, 15 : 1463 - 1479
  • [32] Distinct roles of GSK-3α and GSK-3β phosphorylation in the heart under pressure overload
    Matsuda, Takahisa
    Zhai, Peiyong
    Maejima, Yasuhiro
    Hong, Chull
    Gao, Shumin
    Tian, Bin
    Goto, Kazumichi
    Takagi, Hiromitsu
    Tamamori-Adachi, Mimi
    Kitajima, Shigetaka
    Sadoshima, Junichi
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (52) : 20900 - 20905
  • [33] Decoding the molecular Symphony: Unravelling neurologically crucial GSK-3 inhibition through 2D QSAR modelling with MLR, PLS, and ANN approaches
    Chauhan, Neha
    Paliwal, Sarvesh
    Sharma, Swapnil
    Jain, Smita
    Madan, Kritika
    Paliwal, Ajita
    Sharma, Pragya
    Mishra, Achal
    Mohite, Popat
    Chidrawar, Vijay
    Singh, Sudarshan
    RESULTS IN CHEMISTRY, 2024, 8
  • [34] 3D-QSAR and Molecular Docking Study on Maleimide-Based Glycogen Synthase Kinase 3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis
    Shiri, Fereshteh
    Shahraki, Alireza
    Nejati-Yazdinejad, Massoud
    POLYCYCLIC AROMATIC COMPOUNDS, 2020, 40 (03) : 743 - 757
  • [35] 3D QSAR studies on amphiphilic indoles for antimycobacterial activity
    Bahuguna, Aparna
    Bharatam, Prasad V.
    Rawat, Diwan S.
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2021, 35 (03)
  • [36] QSAR 3D STUDIES OF A SERIES OF HUMAN BUTYRYLCHOLINESTERASE INHIBITORS
    Freitas, Humberto F.
    Paz, Odailson S.
    Castilho, Marcelo S.
    QUIMICA NOVA, 2009, 32 (08): : 2114 - U153
  • [37] 3D–QSAR studies of orvinol analogs as κ-opioid agonists
    Wei Li
    Yun Tang
    Qiong Xie
    Wei Sheng
    Zhui-Bai Qiu
    Journal of Molecular Modeling, 2006, 12 : 877 - 884
  • [38] QSAR, Docking, and CoMFA Studies of GSK3 Inhibitors
    Garcia, Isela
    Fall, Yagamare
    Gomez, Generosa
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (24) : 2666 - 2675
  • [39] Portraying the selectivity of GSK-3 inhibitors towards CDK-2 by 3D similarity and molecular docking
    Liliana Pacureanu
    Sorin Avram
    Alina Bora
    Ludovic Kurunczi
    Luminita Crisan
    Structural Chemistry, 2019, 30 : 911 - 923
  • [40] Tax dysregulation of Bcl-3 via inhibition of GSK-3 kinase activity
    Livengood, JL
    Ulloa, A
    Kim, Y
    Nyborg, JK
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2005, 21 (05) : 501 - 501